Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DH1W0G
|
|||
| Drug Name |
VY-AADC
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 2 | [1] | |
| Company |
Voyager Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03562494) VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Voyager Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.